Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAthelney Tst. Regulatory News (ATY)

Share Price Information for Athelney Tst. (ATY)

Share Price is delayed by 15 minutes
Get Live Data
165.00    0.00 (0.00%)
Bid:
140.00
Ask:
190.00
Spread: 50.00 (35.714%)
Market Cap: £3.56m
ATY Live PriceLast checked at - London Stock Exchange

Intraday Athelney Tst. Share Chart

Net Asset Value(s)

2 Sep 2025 09:09

RNS Number : 6444X
Athelney Trust PLC
02 September 2025
 

 

Athelney Trust PLC

 

Legal Entity Identifier:

213800ON67TJC7F4DL05

The unaudited net asset value of Athelney Trust was 183.6p at 31 August 2025.

Fund Manager's comment for August 2025

In the US, growth rebounded in August with Q2 GDP rising 3.3% annualised after a 0.5% Q1 contraction. The upgrade from 3.0% reflected stronger investment and consumer spending, partly offset by softer government outlays and higher imports. Headline CPI held steady at 2.7% in July, while core inflation rose to 3.1% which resulted in the Fed keeping rates at 4.25-4.50% for a fifth meeting.

Europe grew slower in Q2, with GDP rising just 0.1% quarter-on-quarter after increasing by 0.6% in Q1, its weakest pace since late 2023. The moderation reflects earlier activity pulled forward by tariff concerns and lingering uncertainty around US trade policy. Performance varied with Germany and Italy contracting with France, Spain and several smaller economies improving. Inflation remained on target at 2.0% in July, with core inflation at 2.3%. Against this backdrop, the ECB kept its policy rates unchanged, signalling a wait-and-see approach after eight rate cuts.

UK growth moderated but beat forecasts in Q2 2025, with GDP up 0.3% in Q2 after a 0.7% rise in Q1. The BoE delivered a 25bp cut to 4.0%, signalling gradual, data-dependent easing. August PMIs underlined a two-speed UK economy. On the one hand, manufacturing output fell as weak new orders met subdued global demand amid tariff uncertainty with firms reporting faster input cost growth and logistics bottlenecks. Services told a different story with the PMI rising for the fourth straight month and the fastest in a year, fuelled by renewed new orders at home and abroad. Investors, however, are concerned about the UK's fiscal outlook, and this is reflected in the 30-year gilt yield reaching 5.6%, the highest since the late 1990s.

Global equity markets continued to demonstrate resilience in August, with steady gains. The MSCI World Index rose 2.49%, supported by broad based strength across developed markets. In the US, the S&P 500 advanced 1.91% and the Nasdaq up by 1.58%, reflecting sustained investor interest in technology and growth-oriented sectors. Closer to home, large-cap UK equities also delivered positive returns, with the FTSE 100 rising 0.60%. The impact of the recent surge in 30-year gilt yields, which tends to compress equity multiples, especially for smaller companies, was felt by the FTSE 250 and Small Cap indices, which posted negative returns of −1.63% and −2.34% respectively.

In line with broader UK small caps, our NAV total return fell by 2.81% net of fees and expenses. We added to our positions in Auto Trader, Cake Box Holdings, PayPoint and Spectra Systems, businesses we believe combine good economics with sensible prices. We reduced our holding in S&U and exited Alpha Group after it received a takeover offer from US-based Corpay.

During the month, YouGov issued a full year trading update indicating FY25 performance was in line with expectations, with Data Products supported by stable renewals and new customer wins. Other portfolio holdings, including FeverTree, Impax, PayPoint and Rightmove, continued share repurchases which, when done below intrinsic value raise our share of future earnings. The largest contributors to performance were S&U plc, Treatt plc and YouGov, all rising over 5%. Detractors from performance included AEWU REIT, Fever-Tree Drinks and Games Workshop.

 

Fact Sheet

An accompanying fact sheet which includes the information above as well as wider details on the portfolio can be found on the Fund's website www.athelneytrust.co.uk under "About" then select "Latest Monthly Fact Sheet".

Background Information

Dr. Emmanuel (Manny) Pohl AM

Manny is Chairman and Chief Investment Officer of E C Pohl & Co ("ECP"), an investment management company and has been a major shareholder in Athelney trust for many years.

E C Pohl & co is licensed by the Australian Financial services (license no.421704).

www.ecpohl.com

www.ecpam.com

Manny Pohl and the ECP group has AUD2.7bn (£1.5 billion) under its management including four listed investment companies, three listed in Australia and one in the UK:

· Flagship Investments (ASX code:FSI)

 https://flagshipinvestments.com.au

· ECP Emerging Growth (ASX code: ECP)

 https://ecpam.com/emerging

· Global Masters Fund Limited (ASX code: GFL)

 www.globalmastersfund.com.au

· Athelney Trust plc (LSE code: ATY)

 www.athelneytrust.co.uk

Athelney Trust plc Investment Policy

 The investment objective of the Trust is to provide shareholders with prospects of long-term capital growth with the risks inherent in small cap investment minimised through a spread of holdings in quality small cap companies that operate in various industries and sectors. The Fund Manager also considers that it is important to maintain a progressive dividend record.

The assets of the Trust are allocated predominantly to companies with either a full listing on the London Stock Exchange or a trading facility on AIM or ISDX. The assets of the Trust have been allocated in two main ways: first, to the shares of those companies which have grown steadily over the years in terms of profits and dividends but, despite this progress, the market rating is favourable when compared to future earnings and dividends; second, to those companies whose shares are standing at a favourable level compared with the value of land, buildings or cash in the balance sheet.

Athelney Trust was founded in 1994. In 1996 it was one of the ten pioneer members of the Alternative Investment Market ("AIM"). In 2008 the shares became fully listed on the main market of the London Stock Exchange. Athelney Trust has a successful progressive dividend growth record and the dividend has grown every year since 2004. According to the Association of Investment Companies (AIC) Athelney Trust is a "Dividend Hero" being one of only a few investment companies that have increased their dividend every year for 20 years or more. See link

https://www.theaic.co.uk/income-finder/dividend-heroes

Website

www.athelneytrust.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVGIGDCCGGDGUD
Date   Source Headline
25th Jan 201910:08 amRNSDirectorate Change
22nd Jan 20192:52 pmRNSResult of EGM
11th Jan 20193:00 pmRNSEGM Shareholder Statement
4th Jan 201910:26 amRNSNet Asset Value(s)
28th Dec 20184:00 pmRNSNotice of Extraordinary General Meeting
19th Dec 20181:43 pmRNSDirector/PDMR Shareholding
19th Dec 20189:09 amRNSDirector/PDMR Shareholding
17th Dec 201811:28 amRNSStatement re Corporate Action
5th Dec 201810:43 amRNSNet Asset Value(s)
3rd Dec 20189:38 amRNSDirectorate Change
5th Nov 20189:39 amRNSNet Asset Value(s)
3rd Oct 20183:20 pmRNSNet Asset Value(s)
1st Oct 201811:43 amRNSDirectorate Change
5th Sep 201810:54 amRNSNet Asset Value(s)
3rd Aug 20188:30 amRNSNet Asset Value(s)
20th Jul 20187:00 amRNSHalf-year Report
4th Jul 20189:48 amRNSNet Asset Value(s)
25th Jun 20189:15 amRNSChange of Adviser
4th Jun 201812:52 pmRNSNet Asset Value(s)
2nd May 20182:12 pmRNSNet Asset Value(s)
30th Apr 20182:03 pmRNSDirectorate Change
16th Apr 20188:54 amRNSDirector/PDMR Shareholding
9th Apr 201811:35 amRNSNet Asset Value(s)
22nd Mar 201810:14 amRNSAGM Statement
6th Mar 201812:50 pmRNSNet Asset Value(s)
16th Feb 20187:00 amRNSAnnual Financial Report
6th Feb 20189:05 amRNSNet Asset Value(s)
3rd Jan 201810:51 amRNSNet Asset Value(s)
5th Dec 201710:15 amRNSNet Asset Value(s)
2nd Nov 201712:52 pmRNSNet Asset Value(s)
3rd Oct 201711:24 amRNSNet Asset Value(s)
4th Sep 201712:00 pmRNSNet Asset Value(s)
3rd Aug 20178:34 amRNSNet Asset Value(s)
25th Jul 20177:00 amRNSHalf-year Report
5th Jul 201710:59 amRNSNet Asset Value(s)
5th Jul 20179:53 amRNSHolding(s) in Company
5th Jun 20179:51 amRNSNet Asset Value(s)
8th May 20179:20 amRNSNet Asset Value(s)
5th Apr 20179:16 amRNSNet Asset Value(s)
31st Mar 201711:52 amRNSAGM Statement
6th Mar 20179:53 amRNSNet Asset Value(s)
24th Feb 20177:00 amRNSAnnual Financial Report
3rd Feb 201712:17 pmRNSNet Asset Value(s)
6th Jan 20178:54 amRNSNet Asset Value(s)
5th Dec 20169:13 amRNSNet Asset Value(s)
3rd Nov 20168:45 amRNSNet Asset Value(s)
4th Oct 20169:34 amRNSNet Asset Value(s)
21st Sep 20169:44 amRNSDirector/PDMR Shareholding
2nd Sep 201612:35 pmRNSNet Asset Value(s)
2nd Aug 20168:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.